A practical reference on SR9009: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-21 and is reviewed periodically as new material appears.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small molecule; not a steroid or peptide. |
| Primary targets | NR1D1 and NR1D2 | Also known as REV-ERBα and REV-ERBβ. |
| Studied routes | Intraperitoneal in rodents | Oral bioavailability in humans is not established. |
| Human approval | No approved therapeutic indication | No recognized clinical use. |
| Key uncertainty | Human physiological effects | Preclinical findings may not translate. |
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
These performances can be found on their social media accounts, such as YouTube and Facebook. In addition, they collaborated with Dave Mason for a cover of Traffic's "Feelin' Alright" and Peter Frampton for a cover of Eric Clapton's "Let it Rain". On August 6, 2021, the Doobie Brothers released the EP of four songs that would eventually be featured on their fifteenth studio album. These songs included Johnston's "Don't Ya Mess with Me" and "Oh Mexico" along with Simmons's "Better Days" and "Cannonball". After just over 18 months of not being able to tour due to the COVID-19 pandemic, the band (with McDonald back in the fold) finally began their 50th Anniversary Tour at the Iowa State Fair on Sunday, August 22, 2021. The first leg of the tour concluded at the PPL Center in Allentown, Pennsylvania on October 29, 2021, and the second leg began in West Palm Beach, Florida on June 2, 2022. Bill Payne left the touring band at the end of the first leg, citing his desire to commit "100%" to Little Feat. He was not replaced, and the tour continued with McDonald returning to his original role of primary keyboardist. The Doobie Brothers were featured musical guests on Jimmy Kimmel Live! on Thursday, September 23, 2021. On October 29, 2021, the band released Liberté, their fifteenth full-length studio album and first album of original material in 11 years. All of the tracks on the album were co-written with John Shanks. Shanks is known for his work with Bon Jovi, Sheryl Crow, and Melissa Etheridge, to name a few. Original drummer John Hartman died on December 29, 2021.
Each tissue returns to its equilibrium state after excitation by the independent relaxation processes of T1 (spin-lattice; that is, magnetization in the same direction as the static magnetic field) and T2 (spin–spin; transverse to the static magnetic field). To create a T1-weighted image, magnetization is allowed to recover before measuring the MR signal by changing the repetition time (TR). This image weighting is useful for assessing the cerebral cortex, identifying fatty tissue, characterizing focal liver lesions, and in general, obtaining morphological information, as well as for post-contrast imaging.
Rhodesia began to lose vital economic and military support from South Africa, which, while sympathetic to the white minority government, never accorded it diplomatic recognition. The South African government placed limits on the fuel and munitions they supplied to the Rhodesian military. They also withdrew the personnel and equipment that they had previously provided to aid the war effort, though covert military support continued. In 1976, the South African government and United States governments worked together to place pressure on Smith to agree to a form of majority rule. In response to the initiative of United States Secretary of State Henry Kissinger, in 1976 Ian Smith accepted the principle of black majority rule within two years. The Rhodesians now offered more concessions, but those concessions, focused on reaching an "internal settlement" with moderate black leaders, were insufficient to end the war. At the time, some Rhodesians said the still embittered history between the British-dominated Rhodesia and the Afrikaner-dominated South Africa partly led the South African government to withdraw its aid to Rhodesia. Ian Smith said in his memoirs that even though many white South Africans supported Rhodesia, South African Prime Minister John Vorster's policy of détente with the black African states ended up with Rhodesia being offered as the "sacrificial lamb" to buy more time for South Africa. Other observers perceived South Africa's distancing itself from Rhodesia as being an early move in the process that led to majority rule in South Africa itself.
Sources: en.wikipedia.org
Also in 1992, the Dow Corning Corporation, a silicone products and breast implant manufacturer, announced the discontinuation of five implant-grade silicones, but would continue producing 45 other, medical-grade, silicone materials—three years later, in 1995, the Dow Corning Corporation went bankrupt when it faced large class action lawsuits claiming a variety of illnesses.
"Any individual who is not a member of a federally recognized Cherokee tribe, in academia or otherwise, is hereby discouraged from claiming to speak as a Cherokee, or on behalf of Cherokee citizens, or using claims of Cherokee heritage to advance his or her career or credentials." – Joint Council of the Cherokee Nation and the Eastern Band of the Cherokee Indians The United Keetoowah Band did not sign or approve the resolution. The Cherokee Nation acknowledges the existence of people of Cherokee descent "... in states such as Arkansas, Kansas, Missouri, and Texas," who are Cherokee by ancestry but who are not considered citizens of the Cherokee Nation.
=== Part one === In 1897, in Idris, ten-year-old Lucie Herondale, daughter of Shadowhunter William "Will" Herondale, and half warlock/half Shadowhunter Theresa "Tessa" Gray, gets lost in the forest. She finds her way back with the help of a mysterious young boy. Six years later, in 1903, James Herondale and his friends, his parabatai Matthew Fairchild (son of Charlotte Fairchild), Thomas Lightwood, and Christopher Lightwood, defeat the first demon they have seen in a year. The demon recognizes James, who falls into the shadow realm (a unique power as a result of his warlock heritage) for the first time in 3 years. Meanwhile, Cordelia Carstairs enters the London society along with her brother Alastair and mother Sona. Her father has been arrested for supposedly mishandling a vampire raid, and the Carstairs wish to make powerful allies in London to save their reputation. The Carstairs are greeted by Tessa, James (Cordelia's childhood friend who she has a crush on), and Lucie (James' sister). Cordelia believes that her feelings for James might be requited. At the next day's ball, James requests Cordelia dance with him, but disappoints her when he suddenly leaves to greet Grace Blackthorn, the adopted ward of Tatiana Blackthorn. James met Grace in 1899, and has been in love with her since he was 13 years old. Lucie sees the mysterious boy from her childhood, who reveals himself to be the ghost of Jesse Blackthorn, the late son of Tatiana. His mother asked Downworlders to preserve his body, so his spirit has remained trapped in the in-between.
Sources: en.wikipedia.org
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.
REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.
Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.